HSA — authorised 9 November 2018
- Marketing authorisation holder: MYLAN IRELAND LTD
- Status: likely_approved
HSA authorised Yupelri on 9 November 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 9 November 2018.
MYLAN IRELAND LTD holds the Singaporean marketing authorisation.